In Zucker (fa/fa) rats, the FXR agonist obeticholic acid (OCA) activated FXR, eventually preventing steatosis, obesity, and insulin resistance [182]. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.